Nutex Health (NUTX) to Release Earnings on Tuesday

Nutex Health (NASDAQ:NUTXGet Free Report) is projected to post its Q1 2025 quarterly earnings results after the market closes on Tuesday, May 13th. Analysts expect Nutex Health to post earnings of ($0.15) per share and revenue of $81.09 million for the quarter.

Nutex Health (NASDAQ:NUTXGet Free Report) last posted its earnings results on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, beating the consensus estimate of ($0.09) by $11.21. The company had revenue of $81.30 million for the quarter, compared to analyst estimates of $81.13 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Nutex Health Stock Up 0.0%

Nutex Health stock opened at $120.73 on Monday. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.74 and a current ratio of 1.77. The firm has a market capitalization of $667.40 million, a price-to-earnings ratio of -12.86 and a beta of -0.10. Nutex Health has a fifty-two week low of $4.16 and a fifty-two week high of $152.51. The stock’s fifty day moving average is $91.15 and its two-hundred day moving average is $57.22.

Analysts Set New Price Targets

Separately, Maxim Group upped their target price on Nutex Health from $75.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, April 8th.

Read Our Latest Analysis on Nutex Health

Insider Buying and Selling at Nutex Health

In related news, CFO Jon Christian Bates acquired 1,000 shares of Nutex Health stock in a transaction dated Tuesday, April 8th. The shares were acquired at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the transaction, the chief financial officer now directly owns 4,888 shares of the company’s stock, valued at $399,887.28. The trade was a 25.72% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 38.52% of the stock is owned by corporate insiders.

Institutional Trading of Nutex Health

An institutional investor recently raised its position in Nutex Health stock. Bank of America Corp DE grew its position in shares of Nutex Health Inc. (NASDAQ:NUTXFree Report) by 6,590.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,074 shares of the company’s stock after acquiring an additional 2,043 shares during the quarter. Bank of America Corp DE’s holdings in Nutex Health were worth $66,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 5.32% of the company’s stock.

About Nutex Health

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Featured Articles

Earnings History for Nutex Health (NASDAQ:NUTX)

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.